2016年3月期 決算説明会 - 日本ライフライン株式会社 | …124 2,804 '15/3実績...
TRANSCRIPT
-
20163
2016531
-
2
20163
20173
-
2016320173
-
1,124
2,804
'15/3 '16/3
20163
4
25,696 30,540
'15/3 '16/3
1,845
3,700
'15/3 '16/3
+18.9 +100.5 +149.4
-
20163
5
2015/3
2016/3
15/4/30
2016/3
25,696 29,584 30,540 +18.9% +3.2%
13,956 16,314 17,250 +23.6% +5.7% 54.3 55.1% 56.5 +2.2P +1.4P
1,845 2,785 3,700 +100.5% +32.8% 7.2% 9.4% 12.1% +4.9P +2.7P
1,124 2,171 2,804 +149.4% +29.2% 4.4% 7.3% 9.2% +4.8 +1.9P
-
20163
6
4,173 5,557
11,448 14,371
6,232
7,158 2,617
2,252 1,224
1,200 25,696
30,540
0
10,000
20,000
30,000
'15/3 '16/3
+33.2
EP/ABL+25.5
+14.9
13.9
+18.9
-
7
+791
3,737
783
905
916
2,945
CF
CF
CF
4,514 2,331
2,105 1,028 814 2,239
+1,346 1,805
294
1,100 4,635
2,562 1,950 323
-
2,804 3,102
'16/3 '17/3
20173
8
30,540 34,699
'16/3 '17/3
3,700 4,686
'16/3 '17/3
+13.6 +26.7 +10.6
-
20173
9
2015/32016/3
2017/3
25,696 30,540 34,699 +13.6%
13,956 17,250 19,808 +14.8% 54.3 56.5 57.1% +0.6P
1,845 3,700 4,686 +26.7% 7.2% 12.1% 13.5% +1.4P
1,124 2,804 3,102 +10.6% 4.4% 9.2% 8.9% 0.3
-
///
10
16/3
2013/3 2014/3 2015/3 2016/3 2017/3()
1,336 1,901 331 1,752 1,025
565 576 770 717 987
554 636 794 933 1,086
595 734 759 795 883
519 549 570 610 684
-
11
2015/3 2016/3 2017/3
3,503 13.6% 4,804 15.7% 37.2% 5,425 15.6% 12.9%
ICD 593 2.3% 624 2.0% 5.3% 924 2.7% 48.0%
76 0.3% 127 0.4% 66.9% 145 0.4% 14.2%AED
4,173 16.2% 5,557 18.2% 33.2% 6,495 18.7% 16.9%
EP 7,987 31.1% 10,451 34.2% 30.9% 11,509 33.2% 10.1%
ABL 1,440 5.6% 1,335 4.4% 7.3% 1,189 3.4% 10.9%
2,020 7.9% 2,584 8.5% 27.9% 2,760 8.0% 6.8%
EP/ABL 11,448 44.6% 14,371 47.1% 25.5% 15,458 44.5% 7.6%
1,503 5.9% 1,347 4.4% 10.4% 1,810 5.2% 34.3%
317 1.2% 149 0.5% 52.9% 78 0.2% 47.5%
4,411 17.2% 5,661 18.5% 28.3% 6,971 20.1% 23.1%
6,232 24.3% 7,158 23.4% 14.9% 8,859 25.5% 23.8%
975 3.8% 893 2.9% 8.4% 865 2.5% 3.2%
437 1.7% 436 1.4% 0.2% 412 1.2% 5.7%
1,203 4.7% 921 3.0% 23.4% 1,374 4.0% 49.2% 2,617 10.2% 2,252 7.4% 13.9% 2,652 7.6% 17.7%
1,224 4.8% 1,200 3.9% 2.0% 1,233 3.6% 2.7%
25,696 100.0% 30,540 100.0% 18.9% 34,699 100.0% 13.6%
-
12
2015/3 2016/3 2017/3
25,696 100.0% 30,540 100.0% 18.9% 34,699 100.0% 13.6%
11,739 45.7% 13,289 43.5% 13.2% 14,890 42.9% 12.0%
13,956 54.3% 17,250 56.5% 23.6% 19,808 57.1% 14.8%
12,111 47.1% 13,550 44.4% 11.9% 15,122 43.6% 11.6%
1,845 7.2% 3,700 12.1% 100.5% 4,686 13.5% 26.7%
282 1.1% 240 0.8% 14.8% 217 0.6% 9.6%
90 0.4% 365 1.2% 305.9% 71 0.2% 80.5%
2,037 7.9% 3,574 11.7% 75.5% 4,832 13.9% 35.2%
83 0.3% 1,104 3.6% 1220.3% 24 0.1% 97.8%
162 0.6% 163 0.5% 0.9% 8 0.0% 94.5%
1,958 7.6% 4,514 14.8% 130.5% 4,847 14.0% 7.4%
833 3.2% 1,710 5.6% 105.1% 1,745 5.0% 2.1% 1,124 4.4% 2,804 9.2% 149.4% 3,102 8.9% 10.6%
-
16/3
14
3,503
4,804
ICD593
ICD624
76
127
4,173
5,557
'15/3 '16/3
MRI
MRIKORA100
ICD ICD
PLATINIUM
+33.2
PLATINIUM VR/DR
-
17/3
15
MRI
KORA2503
ICD PLATINIUMCRT-D
2Q
4,804
5,425
ICD624
ICD924
127
145 5,557
6,495
'16/3 '17/3
+16.9
KORA250
-
17/3
16
8,676 6,610
4,173 5,557
6,495
0
5,000
10,000
'13/3 '14/3 '15/3 '16/3 '17/3
MRI
15/3KORA100
16/3KORA250
12/10MRI
-
EP/ 16/3
17
EP7,987
EP10,451
ABL1,440
ABL1,335
2,020
2,584 11,448
14,371
'15/3 '16/3
EP BeeAT
Esophastar
RF
+25.5
BeeATShock AT
-
EP/ 16/3
18
Esophastar AF
575
Esophastar
-
EP/ 17/3
19
AF
BeeAT RF
EsophastarEP
10,451
EP11,509
ABL1,335
ABL1,189
2,584
2,760
14,371 15,458
'16/3 '17/3
+7.6
RF
-
EP/ 17/3
20
0
5,000
10,000
15,000
20,000
0
10,000
20,000
30,000
40,000
'12/3 '13/3 '14/3 '15/3 '16/3 '17/3
EP/ABL
AF
BeeAT
RF
Esophastar
(AF)
-
16/3
21
4,411
5,661
1,503
1,347 317
149 6,232 7,158
'15/3 '16/3
J-Graft
4 12 CROWN PRT
+14.9
CROWN PRT
-
16/3
22
AFX 1 NELLIX
AFX AFX
-
16/3
23
J-Graft J-Graft RELAY Plus AFX
JUNKEN MEDICAL JUNKEN MEDICAL Bolton Medical Endologix
NEW
No.1
-
16/3
24
0
5,000
10,000
15,000
20,000
2012 2013 2014 2015
-
17/3
25
AFX
SOLO SMART
5,661
6,971
1,347
1,810
149
78
7,158
8,859
'16/3 '17/3
+23.8
-
17/3
26
SOLO SMART 4
PERCEVAL
SOLO SMART
-
16/3
27
975
893
437
436
1,203
921
2,617 2,252
'15/3 '16/3
canPass Pantera LEO
GuideLiner
13.9
-
16/3
28
Figulla Flex 2
Figulla Flex
-
17/3
29
GuideLiner Figulla Flex
893
865
436
412
921
1,374
2,252 2,652
'16/3 '17/3
+17.7
-
30
8,184 10,274
13,027
16,638 17,619 40.4%45.0%
53.6% 56.9% 52.9%
0.0%
25.0%
50.0%
0
5,000
10,000
15,000
20,000
25,000
'13/3 '14/3 '15/3 '16/3 '17/3
EP/ABL / /OSG
-
4
-
32
-
33
20203
452
15
-
34
20203
452
15
20213
578
18
-
295
452
305 347
522 578
0
100
200
300
400
500
600
700
'16/3 '17/3 '18/3 '19/3 '20/3 '21/3
352013/5/15
/
202157818
-
36
20213
578
18
-
37
-
38
MRIPMICDAED
MRICRT-DAEDCPR*
*Cardio Pulmonary Resuscitation
-
39
/
AFBeeATRFEsophastar
ABL
-
40
NELLIXEVAS*
*EndoVascular Aneurysm Sealing
-
41
DCB*PCI
*Drug Coating Balloon
-
42
OSG
-
... for Patient Comfort.
-
452013/5/15
2-2-20
198126
7575
2,115
795/61020163
34ACCADEMIA
JUNKEN MEDICALSYNEXMEDHONG KONGLTD.
-
462013/5/15
0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
(93)
AVE(99)JASDAQ
ICD
EP
CRM
JUNKEN MEDICALJ-Graft
-
472013/5/15
EP/
ICD
CRT-DAED
ICD
CRT-DAED
EP/
EP
EP/
EP
EP/
-
48
-
LivaNova
ICDLivaNova
AEDNANOOMTECH
CRT-DLivaNova
ICD
49
-
/
50
EP
EP
BAYLIS MEDICAL
-
51
LivaNova
(LivaNova)
JUNKEN MEDICAL
BOLTON MEDICAL
JUNKEN MEDICAL
-
52
(Vascular Solutions)
-
53
TEL: 03-6711-5214E-Mail: [email protected]
URL: http://www.jll.co.jp